Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Armario, X; Carron, J; Simpkin, AJ; Elhadi, M; Kennedy, C; Abdel-Wahab, M; Bleiziffer, S; Lefèvre, T; Wolf, A; Pilgrim, T; Villablanca, PA; Blackman, DJ; Van, Mieghem, NM; Hengstenberg, C; Swaans, MJ; Prendergast, BD; Patterson, T; Barbanti, M; Webb, JG; Behan, M; Resar, J; Chen, M; Hildick-Smith, D; Spence, MS; Zweiker, D; Bagur, R; Teles, R; Ribichini, FL; Jagielak, D; Park, DW; Kornowski, R; Wykrzykowska, JJ; Bunc, M; Estévez-Loureiro, R; Poon, K; Götberg, M; Jeger, RV; Ince, H; Packer, EJS; Angelillis, M; Nombela-Franco, L; Guo, Y; Savontaus, M; Al-Moghairi, AM; Parasca, CA; Kliger, C; Roy, D; Molnár, L; Silva, M; White, J; Yamamoto, M; Carrilho-Ferreira, P; Toggweiler, S; Voudris, V; Ohno, Y; Rodrigues, I; Parma, R; Ojeda, S; Toutouzas, K; Regueiro, A; Grygier, M; AlMerri, K; Cruz-González, I; Fridrich, V; de, la, Torre, Hernández, JM; Noble, S; Kala, P; Asmarats, L; Kurt, IH; Bosmans, J; Erglis, M; Casserly, I; Iskandarani, D; Bhindi, R; Kefer, J; Yin, WH; Rosseel, L; Kim, HS; O'Connor, S; Hellig, F; Sztejfman, M; Mendiz, O; Pineda, AM; Seth, A; Pllaha, E; de, Brito, FS; Bajoras, V; Balghith, MA; Lee, M; Eid-Lidt, G; Vandeloo, B; Vaz, VD; Alasnag, M; Ussia, GP; Tay, E; Mayol, J; Gunasekaran, S; Sardella, G; Buddhari, W; Kao, HL; Dager, A; Tzikas, A; Gudmundsdottir, IJ; Edris, A; Gutiérrez, Jaikel, LA; Arias, EA; Al-Hijji, M; Ertürk, M; Conde-Vela, C; Boljević, D; Ferrero, Guadagnoli, A; Hermlin, T; ElGuindy, AM; Lima-Filho, MO; de, Moura, Santos, L; Perez, L; Maluenda, G; Akyüz, AR; Alhaddad, IA; Amin, H; So, CY; Al, Nooryani, AA; Vaca, C; Albistur, J; Nguyen, QN; Arzamendi, D; Grube, E; Modine, T; Tchétché, D; Hayashida, K; Latib, A; Makkar, RR; Piazza, N; Søndergaard, L; McEvoy, JW; Mylotte, D.
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study.
JACC Cardiovasc Interv. 2023;
Doi: 10.1016/j.jcin.2023.10.041
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Zweiker David
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays. OBJECTIVES: The study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity. METHODS: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses. RESULTS: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (-52%; P = 0.001), Central-South America (-33%; P < 0.001), and Asia (-29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity. CONCLUSIONS: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises.
- Find related publications in this database (Keywords)
-
aortic valve stenosis
-
coronavirus disease 2019
-
transcatheter aortic valve replacement
-
valvular heart disease